SCHEMBL4379412

SCHEMBL4379412

O=C(O)CCC[C@@H]1CN2CCC1CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SAE1 Q9UBE0 1/20 0.38
▸ UBA2 Q9UBT2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28682845 0.98 ALOX5 (0.41) ALOX5HSD17B10MEN1KMT2APOLB
SCHEMBL2092979 0.86 CHRNA7 (0.41) MEN1KMT2APOLBALDH1A1L3MBTL1
SCHEMBL21063738 0.77 CHRNA7 (0.41) MEN1KMT2APOLBCHRNA7CHRM2
SCHEMBL21063808 0.77 CHRNA7 (0.41) MEN1KMT2APOLBCHRNA7CHRM2
SCHEMBL7328436 0.77 CHRNA7 (0.37) MEN1KMT2APOLBALDH1A1CHRNA7
Hydrochloric Acid SCHEMBL23406281 0.76 SLC6A12 (0.42) MEN1KMT2APOLBCHRNA7CHRM2
SCHEMBL29271818 0.76 CHRNA7 (0.40) MEN1KMT2APOLBCHRNA7CHRM2
SCHEMBL7323705 0.76 CHRNA7 (0.35) MEN1KMT2APOLBALDH1A1CHRNA7
Hydrochloric Acid SCHEMBL26105242 0.76 SLC6A12 (0.42) MEN1KMT2APOLBCHRNA7CHRM2
Hydrochloric Acid SCHEMBL7362613 0.76 CHRNA7 (0.35) MEN1KMT2APOLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867654-B1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE QUINUCLIDINOL NAGOYA IND SCIENCE RES INST (JP) 2014-06-11 — — EP disclosed
US-8212037-B2 Process for production of optically active quinuclidinols KANTO KAGAKU KABUSHIKI KAISHA (JP) 2012-07-03 — — US disclosed
US-20090216019-A1 Process for Production of Optically Active Quinuclidinols KANTO KAGAKU KABUSHIKI KAISHA 2009-08-27 — — US disclosed
EP-1867654-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE QUINUCLIDINOL Nagoya Industrial Science Research Institute (JP) 2007-12-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090216019-A1 Process for Production of Optically Active Quinuclidinols NQO2, ADH7, MRPL21 ALOX5 2136/4885HSD17B10 2338/4885MEN1 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback